Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

Abstract Background Many men with prostate cancer will be exposed to androgen deprivation therapy (ADT). While evidence-based ADT use is common, ADT is also used in cases with no or limited evidence resulting in more harm than benefit, i.e., overuse. Since there are risks of ADT (e.g., diabetes, ost...

ver descrição completa

Detalhes bibliográficos
Principais autores: Ted A. Skolarus, Sarah T. Hawley, Jane Forman, Anne E. Sales, Jordan B. Sparks, Tabitha Metreger, Jennifer Burns, Megan V. Caram, Archana Radhakrishnan, Lesly A. Dossett, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Jennifer Dunsmore, Steven Maclennan, Sameer Saini, Brent K. Hollenbeck, Vahakn Shahinian, Daniela A. Wittmann, Varad Deolankar, S. Sriram
Formato: Artigo
Idioma:English
Publicado em: BMC 2024-04-01
coleção:Implementation Science Communications
Assuntos:
Implementation
Behavior change
De-implementation
Low-value
Intervention
Behavioral theory
Acesso em linha:https://doi.org/10.1186/s43058-024-00576-x

Internet

https://doi.org/10.1186/s43058-024-00576-x

Registros relacionados